Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

PATH earnings analysis

Filed September 8, 2026 · Our reading of the company's report

The latest report

UiPath delivered a positive quarter, with $410.256 million of revenue and $0.15 of diluted EPS beating consensus by 3.1% and 15.4%, respectively. GAAP operating income was $31.604 million, while liquidity totaled $1.405…

Read full summary

UiPath delivered a positive quarter, with $410.256 million of revenue and $0.15 of diluted EPS beating consensus by 3.1% and 15.4%, respectively. GAAP operating income was $31.604 million, while liquidity totaled $1.405 billion across cash and marketable securities. The outlook was raised for Q3 revenue to $440 million-$445 million, although foreign-exchange exposure remains material, with a hypothetical 10% currency move representing a $39.8 million estimated translation impact.

Read the original on SEC.gov

Gross and operating margin

How much of each revenue dollar the business keeps.

87% Gross margin Operating margin Mar 2024 Sep 2026

One point per quarterly or annual filing. Both margins are shares of that report's revenue.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Mar 2024 Sep 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

Reported figures

Earnings per share
$0.15
Operating margin
7.7%

What stood out

  • Revenue beat consensus

    Revenue was $410.256 million, exceeding the $397.795 million consensus estimate by $12.461 million, or 3.1%.

  • EPS beat consensus

    Diluted EPS was $0.15 versus the $0.13 consensus estimate, a $0.02 beat, or 15.4%.

  • GAAP profitability improved

    GAAP operating income improved to $31.604 million, equivalent to an operating margin of approximately 7.7% on $410.256 million of revenue.

  • Strong liquidity position

    Liquidity remained substantial, with $607.4 million of cash and cash equivalents plus $797.6 million of marketable securities as of July 31, 2026.

  • Controls remained effective

    Management concluded that disclosure controls and procedures were effective at a reasonable assurance level as of July 31, 2026, and identified no material control changes during the quarter.

  • Repurchase authorization remains

    The company retained $413.645 million of authorization under its current $500.0 million repurchase program after purchasing 2.424 million shares at an average price of $9.61 in May.

What to watch

  • Meaningful foreign-exchange exposure

    The filing states that approximately 52% of revenue and 44% of expenses were denominated in non-U.S. dollar currencies. A hypothetical 10% change in foreign-exchange rates would have had an estimated $39.8 million translation impact, and the company had no foreign-currency forward contracts during the six months ended July 31, 2026.

  • Interest-rate and investment risk

    Cash and marketable securities totaled $1.405 billion, including $797.6 million of interest-bearing securities. Although a hypothetical 10% change in interest rates was not material for the six months ended July 31, 2026, investment income and liquidity could still be affected by market-rate changes.

  • Insider selling overhang

    The company disclosed a Rule 10b5-1 plan for its CEO-controlled entity, IceVulcan Investments Limited, to sell up to 5.000 million Class A shares through February 1, 2027, potentially increasing share-sale overhang.

  • No material risk-factor updates

    The 10-Q states there were no material changes to the risk factors previously disclosed in the 2026 Form 10-K. Accordingly, the filing does not identify a new risk-factor change, although it reiterates that control systems provide only reasonable—not absolute—assurance against errors or fraud.

Management's outlook

The provided 10-Q excerpt does not contain new numeric guidance. The accompanying earnings disclosure raised Q3 fiscal 2027 revenue guidance to $440 million-$445 million from $395 million-$400 million, with Q3 ARR guidance of $1.992 billion-$1.997 billion and approximate non-GAAP operating income of $100 million. Full-year revenue guidance was $1.789 billion-$1.794 billion and approximate non-GAAP operating income was $445 million.

Earlier filings 4

10-Q · June 4, 2026

UiPath reported strong Q1 results for fiscal 2027, with revenue of $418.4 million, a 17% increase year-over-year, significantly surpassing estimates of $397 million. EPS also beat expectations at $0.15 versus an…

10-K · March 25, 2026

UiPath’s 10-K reiterates a strategic pivot from rule-based RPA to "agentic" AI-driven automation and positions the UiPath Platform™ (including Automation Cloud™ and UiPath Maestro™) as an enterprise orchestration and…

10-Q · December 8, 2025

UiPath reported strong Q3 results with revenue of $411,113,000 (three months ended October 31, 2025), up $56,460,000 (+15.9%) versus $354,653,000 a year ago, and GAAP diluted EPS of $0.37 versus $(0.02) a year ago.…

10-Q · September 8, 2025

UiPath reported quarterly revenue of $361.7M, up from $316.3M a year ago, with gross profit of $297.3M (82.2% margin) and a GAAP net income of $1.6M (diluted EPS $0.00). Operating loss narrowed materially to $(20.2)M…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.